+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fully MagLev Left Ventricular Assist Device Market - Global Forecast 2026-2032- Product Image
Fully MagLev Left Ventricular Assist Device Market - Global Forecast 2026-2032- Product Image
Sale

Fully MagLev Left Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125744
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fully MagLev Left Ventricular Assist Device Market is projected to reach USD 1.78 Billion in 2026. It is expected to continue growing at a CAGR of 10.83%, reaching USD 3.27 Billion by 2032.

Fully MagLev Left Ventricular Assist Devices: Executive Overview

Fully magnetically levitated left ventricular assist devices (LVADs) use contactless rotor suspension to reduce mechanical friction and eliminate some wear-prone components found in earlier pump designs. Their clinical role is centered on circulatory support for selected patients with advanced heart failure, including bridge-to-transplant, bridge-to-recovery, and destination-therapy pathways. Adoption depends on clinical evidence, patient selection, surgical expertise, reimbursement, device durability, infection management, and post-implant monitoring.

Clinical Practice Is Shifting Toward Durability and Patient-Centered Support

The LVAD landscape is being reshaped by progress in pump engineering, smaller device profiles, improved driveline management, and greater emphasis on long-term quality of life. Fully magnetically levitated systems address important engineering objectives by limiting blood-contacting mechanical interfaces and supporting more consistent pump operation. At the same time, clinicians continue to balance survival and functional improvement against bleeding, stroke, infection, right-heart failure, anticoagulation requirements, and the burden of external power and driveline care. Multidisciplinary selection and structured follow-up are therefore becoming as important as the implant itself.

Artificial Intelligence Strengthens Selection, Monitoring, and Risk Management

Artificial intelligence can support LVAD care by combining device logs, laboratory results, imaging, hemodynamic measurements, and clinical histories to identify patterns associated with thrombosis, suction events, infection, right-heart dysfunction, or impending decompensation. Predictive tools may help prioritize follow-up and improve remote surveillance, but their value depends on representative training data, transparent validation, clinically meaningful endpoints, cybersecurity, and integration into care teams. AI should augment-not replace-specialist judgment, particularly when decisions involve implantation, anticoagulation, transplant eligibility, or urgent intervention.

Regional Priorities Vary With Heart-Failure Burden and Care Infrastructure

North America combines established advanced-heart-failure programs with sophisticated surgical, reimbursement, and remote-monitoring capabilities. Europe benefits from specialized centers and coordinated clinical networks, although national assessment and procurement processes differ. Asia-Pacific includes advanced programs in Australia, Japan, and South Korea alongside rapidly developing capacity in China and India, where access, training, and follow-up infrastructure remain uneven. Latin America is shaped by concentrated specialist services, affordability constraints, and transplant-system variability. The Middle East is investing in tertiary cardiac services, with access influenced by referral networks and public-sector capacity. Africa faces the greatest infrastructure and affordability challenges, making training, referral pathways, infection prevention, and reliable postoperative support central to responsible adoption.

Economic and Security Alliances Shape Access, Standards, and Collaboration

ASEAN countries are likely to benefit from shared training, referral coordination, and regional procurement approaches, while differences in reimbursement and surgical capacity remain important. BRICS members span highly developed and emerging cardiac systems, creating opportunities for technology collaboration alongside uneven access. The European Union can support evidence harmonization and cross-border clinical learning through common regulatory and health-technology frameworks. G7 members generally possess strong research, cardiac-surgery, and monitoring capabilities, but must still address affordability and equitable access. GCC states have substantial tertiary-care ambitions and can serve as referral hubs, while NATO members may contribute to resilient supply chains, emergency preparedness, and cross-border clinical cooperation without implying identical health-system policies.

Country-Level Readiness Depends on Specialist Capacity and Long-Term Follow-Up

The United States and Canada have mature advanced-heart-failure services, while the United Kingdom, Germany, France, Italy, and Spain rely on established but nationally distinct reimbursement, referral, and transplant pathways. Australia and Japan have experienced specialist centers and structured cardiac care, with geography making continuity important. South Korea has advanced tertiary hospitals and device expertise. China and India are expanding complex cardiac capabilities, but access and follow-up differ substantially across regions. Brazil and Mexico have concentrated expertise with persistent affordability and coverage considerations. Russia’s access is influenced by specialist-center availability, procurement, and broader health-system conditions. Across all listed countries, safe use requires trained implant teams, anticoagulation oversight, infection prevention, emergency protocols, and durable patient education.

Industry Leaders Should Prioritize Evidence, Infrastructure, and Patient Support

Leaders should generate comparative evidence on survival, functional status, complications, rehospitalization, and quality of life using standardized definitions and meaningful follow-up periods. They should invest in implant-center training, credentialing, simulation, remote monitoring, cybersecurity, and rapid-response pathways for device alarms. Product development should focus on smaller profiles, quieter operation, improved power solutions, driveline infection reduction, and simpler patient interfaces. Partnerships with hospitals, payers, transplant programs, and patient organizations can improve referral and continuity. AI deployments should use prospective validation, bias assessment, human oversight, and clear accountability. Access strategies should reflect local infrastructure rather than relying on a single global implementation model.

Methodology: Evidence-Based Assessment of Technology, Care Pathways, and Access

This executive summary uses the market definition of fully magnetically levitated left ventricular assist devices and synthesizes established clinical, technological, regulatory, and health-system considerations. The assessment distinguishes device characteristics from broader LVAD care requirements and considers how infrastructure, reimbursement, specialist training, transplant pathways, and patient support influence implementation. Regional, group, and country observations are framed qualitatively and avoid unsupported estimates, market shares, forecasts, or company-specific claims. Conclusions should be validated against current peer-reviewed evidence, regulatory documents, clinical guidelines, registry findings, and local reimbursement policies before operational decisions are made.

Responsible Adoption Depends on Clinical Value and Complete Care Ecosystems

Fully magnetically levitated LVADs represent an important engineering advance within advanced-heart-failure therapy, but device performance alone does not determine outcomes. Benefits depend on appropriate patient selection, experienced multidisciplinary teams, reliable anticoagulation and infection management, durable power and monitoring arrangements, and equitable access to follow-up. Regional and country differences make adaptable implementation essential. The strongest pathway forward combines rigorous evidence, responsible AI, resilient care infrastructure, and sustained attention to patient quality of life.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fully MagLev Left Ventricular Assist Device Market, by Power Source
7.1. Introduction
7.2. External Battery
7.3. Mains Power
8. Fully MagLev Left Ventricular Assist Device Market, by Patient Age
8.1. Introduction
8.2. Adult
8.3. Pediatric
9. Fully MagLev Left Ventricular Assist Device Market, by Application
9.1. Introduction
9.2. Bridge To Recovery
9.3. Bridge To Transplant
9.4. Destination Therapy
10. Fully MagLev Left Ventricular Assist Device Market, by End User
10.1. Introduction
10.2. Cardiac Centers
10.3. Hospitals
11. Fully MagLev Left Ventricular Assist Device Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
12. Fully MagLev Left Ventricular Assist Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Fully MagLev Left Ventricular Assist Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Fully MagLev Left Ventricular Assist Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Berlin Heart GmbH
16.3. BiVACOR Inc.
16.4. CH Biomedical Co., Ltd.
16.5. CorWave SA
16.6. Evaheart Inc.
16.7. Jarvik Heart Inc.
16.8. Leviticus Cardio LLC
16.9. Medtronic plc
16.10. ReliantHeart Inc.
16.11. Shenzhen Core Medical Technology Co., Ltd.
16.12. Suzhou Tongxin Medical Devices Co., Ltd.
16.13. SynCardia Systems LLC
16.14. Teleflex Incorporated
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Fully MagLev Left Ventricular Assist Device Market, Years Considered for the Study
FIGURE 2. Global Fully MagLev Left Ventricular Assist Device Market, Research Design
FIGURE 3. Global Fully MagLev Left Ventricular Assist Device Market, Research Framework
FIGURE 4. Global Fully MagLev Left Ventricular Assist Device Market, Data Triangulation
FIGURE 5. Global Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2025 vs 2032 (%)
FIGURE 7. Global Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2025 vs 2032 (%)
FIGURE 9. Global Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Fully MagLev Left Ventricular Assist Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Fully MagLev Left Ventricular Assist Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Fully MagLev Left Ventricular Assist Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Fully MagLev Left Ventricular Assist Device Market Segmentation & Coverage
TABLE 2. Global Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 4. Global External Battery Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global External Battery Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global External Battery Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Mains Power Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Mains Power Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Mains Power Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 11. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 18. Global Bridge To Recovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Bridge To Recovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Bridge To Recovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Bridge To Transplant Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Bridge To Transplant Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Bridge To Transplant Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Destination Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Destination Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Destination Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 28. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 35. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Distributor Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Distributor Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Distributor Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 44. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 48. North America Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. North America Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 50. North America Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 51. North America Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 52. North America Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. North America Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 54. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 56. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 57. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Latin America Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. Europe Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Europe Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 62. Europe Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 63. Europe Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Europe Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Europe Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 68. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 69. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Middle East Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Africa Fully MagLev Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Africa Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 74. Africa Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 75. Africa Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Africa Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Africa Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Global Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 81. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 82. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. ASEAN Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. GCC Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. GCC Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 87. GCC Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 88. GCC Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. GCC Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. GCC Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. European Union Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 93. European Union Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 94. European Union Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. European Union Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. European Union Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 99. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 100. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. BRICS Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. G7 Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. G7 Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 105. G7 Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 106. G7 Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. G7 Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. G7 Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. NATO Fully MagLev Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. NATO Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 111. NATO Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 112. NATO Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. NATO Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. NATO Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Global Fully MagLev Left Ventricular Assist Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. United States Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 117. United States Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 118. United States Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 119. United States Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. United States Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. United States Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Canada Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 123. Canada Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 124. Canada Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 125. Canada Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Canada Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Canada Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Mexico Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 129. Mexico Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 130. Mexico Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 131. Mexico Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Mexico Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Mexico Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Brazil Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 135. Brazil Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 136. Brazil Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 137. Brazil Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Brazil Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Brazil Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 141. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 142. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 143. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. United Kingdom Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Germany Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 147. Germany Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 148. Germany Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 149. Germany Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Germany Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Germany Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. France Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 153. France Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 154. France Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 155. France Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. France Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. France Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Russia Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 159. Russia Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 160. Russia Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 161. Russia Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Russia Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Russia Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Italy Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 165. Italy Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 166. Italy Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 167. Italy Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Italy Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Italy Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Spain Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 171. Spain Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 172. Spain Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 173. Spain Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Spain Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Spain Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. China Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 177. China Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 178. China Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 179. China Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. China Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. China Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. India Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 183. India Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 184. India Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 185. India Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. India Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. India Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Japan Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 189. Japan Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 190. Japan Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 191. Japan Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Japan Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Japan Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Australia Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 195. Australia Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 196. Australia Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 197. Australia Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Australia Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Australia Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. South Korea Fully MagLev Left Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 201. South Korea Fully MagLev Left Ventricular Assist Device Market Size, by Power Source, 2017-2032 (USD Million)
TABLE 202. South Korea Fully MagLev Left Ventricular Assist Device Market Size, by Patient Age, 2017-2032 (USD Million)
TABLE 203. South Korea Fully MagLev Left Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. South Korea Fully MagLev Left Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. South Korea Fully MagLev Left Ventricular Assist Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Global Fully MagLev Left Ventricular Assist Device Market Share, by Key Player, 2025
TABLE 207. Global Fully MagLev Left Ventricular Assist Device Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • CH Biomedical Co., Ltd.
  • CorWave SA
  • Evaheart Inc.
  • Jarvik Heart Inc.
  • Leviticus Cardio LLC
  • Medtronic plc
  • ReliantHeart Inc.
  • Shenzhen Core Medical Technology Co., Ltd.
  • Suzhou Tongxin Medical Devices Co., Ltd.
  • SynCardia Systems LLC
  • Teleflex Incorporated

Related Topics

Related Reports

MagLev Ventricular Assist Device Market - Global Forecast 2026-2032 - Product Image

MagLev Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Fully MagLev Ventricular Assist Device Market - Global Forecast 2026-2032 - Product Image

Fully MagLev Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Ventricular Assist Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Ventricular Assist Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Left Ventricular Assist Devices Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Left Ventricular Assist Devices Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Left Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Left Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.